AAD 2026Abstract 74486Observational study
Tildrakizumab in Real-World Chinese Psoriasis
Efficacy-Safety Profiles from a 28-Week Prospective Cohort with Geriatric and Metabolic Syndrome Stratification
Liu Q, Kuang Y
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisOlder adultsBiologics
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1793 · Not in PubMed: details from Crossref